ImmuCell (ICCC) News Today $5.49 +0.10 (+1.86%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ImmuCell appoints new CFO to bolster growth strategyApril 9, 2025 | uk.investing.comImmuCell Corporation: ImmuCell Hires Chief Financial OfficerApril 9, 2025 | finanznachrichten.deImmucell reports preliminary Q1 revenue $8.1M vs. $7.3M last yearApril 9, 2025 | markets.businessinsider.comImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025April 8, 2025 | markets.businessinsider.comImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025April 8, 2025 | globenewswire.comImmucell appoints Timothy Fiori as CFOApril 8, 2025 | markets.businessinsider.comImmuCell Names Timothy Fiori Finance ChiefApril 7, 2025 | marketwatch.comImmuCell Hires Chief Financial OfficerApril 7, 2025 | markets.businessinsider.comImmucell initiates Investigational Product use of Re-TainApril 2, 2025 | markets.businessinsider.comImmuCell Announces Initiation of Investigational Product Use of Re-Tain®April 2, 2025 | globenewswire.comImmuCell Full Year 2024 Earnings: US$0.26 loss per share (vs US$0.74 loss in FY 2023)February 27, 2025 | finance.yahoo.comImmuCell Corporation (ICCC) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comImmucell sees FY25 revenue $111M-$113M, consensus $107.93MFebruary 26, 2025 | markets.businessinsider.comImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024February 25, 2025 | globenewswire.comImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024February 20, 2025 | globenewswire.comTop Stock Reports for Apple, Eli Lilly & ShopifyFebruary 14, 2025 | msn.comImmucell settles contamination insurance claim, to pay additional $426,587January 17, 2025 | markets.businessinsider.comImmuCell Corporation: ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination LossesJanuary 17, 2025 | finanznachrichten.deImmuCell settles insurance claim for production lossesJanuary 16, 2025 | msn.comImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination LossesJanuary 16, 2025 | globenewswire.comImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024January 10, 2025 | markets.businessinsider.comImmucell reports preliminary Q4 sales $7.8M vs. $5.1M last yearJanuary 10, 2025 | markets.businessinsider.comImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024January 9, 2025 | globenewswire.comImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023)November 16, 2024 | finance.yahoo.comImmuCell Reports Strong Sales Growth in Q3 2024November 15, 2024 | markets.businessinsider.comImmuCell Corporation (ICCC) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024November 13, 2024 | globenewswire.comImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024November 7, 2024 | globenewswire.comImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024October 8, 2024 | markets.businessinsider.comImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024October 8, 2024 | globenewswire.comImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023)August 16, 2024 | finance.yahoo.comImmuCell Corporation (ICCC) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | seekingalpha.comImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024August 13, 2024 | globenewswire.comImmuCell Corporation (ICCC)July 30, 2024 | finance.yahoo.comImmuCell Corporation (ICCC) stock historical prices & data – Yahoo FinanceJuly 23, 2024 | nz.finance.yahoo.comImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024July 9, 2024 | globenewswire.comImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®June 5, 2024 | globenewswire.comImmuCell to Hold Virtual-Only Annual Meeting of StockholdersJune 4, 2024 | globenewswire.comImmuCell Corporation (NASDAQ:ICCC) Q1 2024 Earnings Call TranscriptMay 16, 2024 | insidermonkey.comImmuCell Corporation (ICCC) Q1 2024 Earnings Call TranscriptMay 15, 2024 | seekingalpha.comICCC Stock Earnings: ImmuCell Reported Results for Q1 2024May 14, 2024 | investorplace.comImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024May 14, 2024 | globenewswire.comImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024May 8, 2024 | globenewswire.comImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024April 10, 2024 | finanznachrichten.deImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024April 9, 2024 | markets.businessinsider.comImmuCell reports preliminary Q1 sales, stock climbs 7%April 9, 2024 | msn.comImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024April 9, 2024 | globenewswire.comImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | finance.yahoo.comImmuCell Corporation (ICCC) Q4 2023 Earnings Call TranscriptFebruary 28, 2024 | seekingalpha.comImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023February 27, 2024 | globenewswire.com Remove Ads Get ImmuCell News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter. Email Address ICCC Media Mentions By Week ICCC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ICCC News Sentiment▼0.470.79▲Average Medical News Sentiment ICCC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ICCC Articles This Week▼20▲ICCC Articles Average Week Remove Ads Get ImmuCell News Delivered to You Automatically Sign up to receive the latest news and ratings for ICCC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OCGN News AMRN News BTMD News SOPH News PLX News TERN News CRDF News GOSS News DSGN News TVGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ICCC) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmuCell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ICCC Stock Free ICCC Stock Alerts